Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Skin disease in HIV-positive persons living in Puerto Rico.

Freytes DM, Arroyo-Novoa CM, Figueroa-Ramos MI, Ruiz-Lebrón RB, Stotts NA, Busquets A.

Adv Skin Wound Care. 2007 Mar;20(3):149-50, 152-6.

PMID:
17473721
2.

The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, Gange S, Barranday Y, Holman S, Weber K, Young MA.

Clin Diagn Lab Immunol. 2005 Sep;12(9):1013-9. Review. No abstract available.

3.

Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.

Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ.

J Natl Cancer Inst. 2004 Jul 21;96(14):1070-6.

PMID:
15265968
4.

Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment.

Dezube BJ, Pantanowitz L, Aboulafia DM.

AIDS Read. 2004 May;14(5):236-8, 243-4, 251-3. Review.

PMID:
15199854
5.

The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.

Mocroft A, Kirk O, Clumeck N, Gargalianos-Kakolyris P, Trocha H, Chentsova N, Antunes F, Stellbrink HJ, Phillips AN, Lundgren JD.

Cancer. 2004 Jun 15;100(12):2644-54.

6.

Eosinophilic pustular folliculitis: a comprehensive review of treatment options.

Ellis E, Scheinfeld N.

Am J Clin Dermatol. 2004;5(3):189-97. Review.

PMID:
15186198
7.

Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus.

Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, Palefsky JM, Strickler HD, Levine AM, Sacks HS, Moxley M, Heather Watts D.

Am J Obstet Gynecol. 2004 May;190(5):1241-8. Erratum in: Am J Obstet Gynecol. 2004 Nov;191(5):1842-4.

PMID:
15167825
8.

The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts.

Silverberg MJ, Ahdieh L, Munoz A, Anastos K, Burk RD, Cu-Uvin S, Duerr A, Greenblatt RM, Klein RS, Massad S, Minkoff H, Muderspach L, Palefsky J, Piessens E, Schuman P, Watts H, Shah KV.

Sex Transm Dis. 2002 Aug;29(8):427-35.

PMID:
12172526
9.

Kaposi's sarcoma in HIV-infected patients: treatment options.

Hermans P.

HIV Med. 2000 Jul;1(3):137-42. Review.

10.

Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.

Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, Mastrorilli E, Taccagni G, Lazzarin A, Uberti-Foppa C.

J Infect Dis. 2001 Sep 1;184(5):547-51. Epub 2001 Aug 9.

PMID:
11494160
11.

Cutaneous warts in HIV-positive patients undergoing highly active antiretroviral therapy.

Rodrigues LK, Baker T, Maurer T.

Arch Dermatol. 2001 Aug;137(8):1103-4. No abstract available.

PMID:
11493111
12.

Prevalence and predictors of skin disease in the Women's Interagency HIV Study (WIHS).

Mirmirani P, Hessol NA, Maurer TA, Berger TG, Nguyen P, Khalsa A, Gurtman A, Micci S, Young M, Holman S, Gange SJ, Greenblatt RM.

J Am Acad Dermatol. 2001 May;44(5):785-8.

PMID:
11312425
13.

Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus.

Ahdieh L, Gange SJ, Greenblatt R, Minkoff H, Anastos K, Young M, Nowicki M, Kovacs A, Cohen M, Muñoz A.

Am J Epidemiol. 2000 Nov 15;152(10):923-33.

PMID:
11092434
14.

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

International Collaboration on HIV and Cancer.

J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30.

PMID:
11078759
15.

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

Hernán MA, Brumback B, Robins JM.

Epidemiology. 2000 Sep;11(5):561-70.

PMID:
10955409
16.

Nongenital dermatologic disease in HIV-infected women.

Barton JC, Buchness MR.

J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):938-48.

PMID:
10365925
17.

Impact of highly active antiretroviral therapy on clinical evolution of genital warts in HIV-infected patients.

Orlando G, Fasolo MM, Signori R, Schiavini M, Casella A, Cargnel A.

AIDS. 1999 Feb 4;13(2):291-3. No abstract available.

PMID:
10202844
18.

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women.

Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R.

J Natl Cancer Inst. 1999 Feb 3;91(3):226-36.

PMID:
10037100
19.

The changing spectrum of the cutaneous manifestations of HIV disease.

Costner M, Cockerell CJ.

Arch Dermatol. 1998 Oct;134(10):1290-2. No abstract available.

PMID:
9801690
20.

Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.

Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD.

AIDS. 1998 Aug 20;12(12):1459-64.

PMID:
9727566

Supplemental Content

Support Center